Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months

Virology Journal

Volumn 10, Issue , 2013, Pages

  Pallister, Jackie A ^a   Klein, Reuben ^a   Arkinstall, Rachel ^a   Haining, Jessica ^a   Long, Fenella ^a   White, John R ^a   Payne, Jean ^a   Feng, Yan Ru ^b   Wang, Lin Fa ^a,c   Broder, Christopher C ^b   Middleton, Deborah ^a  

^a CSIRO   (Australia)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Ferret; Glycoprotein; Hendra virus; Henipavirus; Immunity; Longevity; Nipah virus; Paramyxovirus; Subunit vaccine; Vaccination

Indexed keywords

ADJUVANT; ANTIGEN; OLIGODEOXYNUCLEOTIDE; RECOMBINANT PROTEIN; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BRONCHUS; CONTROLLED STUDY; FERRET; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INOCULATION; LIQUID; LYMPH NODE; MALE; NIPAH VIRUS; NIPAH VIRUS INFECTION; NONHUMAN; NOSE SECRETION; PATHOGENICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; TISSUES; VACCINATION; VIRUS GENOME; VIRUS ISOLATION; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ANIMAL STRUCTURES; ANIMALS; ANTIBODIES, VIRAL; BODY FLUIDS; DISEASE MODELS, ANIMAL; FERRETS; HENIPAVIRUS INFECTIONS; MALE; NIPAH VIRUS; OLIGODEOXYRIBONUCLEOTIDES; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

ANIMALIA; HENDRA VIRUS; HENIPAVIRUS; MUSTELA; NIPAH VIRUS; PARAMYXOVIRIDAE;

EID: 84880084272     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-237     Document Type: Article

References (36)

1. Henipaviruses. Eaton BT, Mackenzie JS, Wang LF, Fields Virology Philadelphia: Lippincott Williams & Wilkins, Knipe DM, Griffin DE, Lamb RA, Straus SE, Howley PM, Martin MA, Roizman B, 2007 1587 1600
2. Cedar virus: a novel virus isolated from Australian bats. Marsh GA, De Jong C, Barr JA, Smith C, Middleton D, Yu M, Todd S, Foord A, Haring V, Payne J, et al. PLoS Pathog 2012 8 1 11
3. Antibodies to Nipah or Nipah-like viruses in bats, China. Li Y, Wang J, Hickey AC, Zhang Y, Wu Y, Zhang H, Yuan J, Han Z, McEachern J, Broder CC, et al. Emerg Infect Dis 2008 14 1974 1976 10.3201/eid1412.080359 19046545
4. Henipavirus RNA in African bats. Drexler JF, Corman VM, Gloza-Rausch F, Seebens A, Annan A, Ipsen A, Kruppa T, Muller MA, Kalko EK, Adu-Sarkodie Y, et al. PLoS One 2009 4 6367 10.1371/journal.pone.0006367 19636378
5. Co-circulation of diverse paramyxoviruses in an urban African fruit bat population. Baker KS, Todd S, Marsh G, Fernandez-Loras A, Suu-Ire R, Wood JL, Wang LF, Murcia PR, Cunningham AA, J Gen Virol 2012 93 850 856 10.1099/vir.0.039339-0 22205718
6. Bats host major mammalian paramyxoviruses. Drexler JF, Corman VM, Muller MA, Maganga GD, Vallo P, Binger T, Gloza-Rausch F, Rasche A, Yordanov S, Seebens A, et al. Nat Commun 2012 3 796 22531181
7. Nipah virus: a recently emergent deadly paramyxovirus. Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, Ksiazek TG, Rollin PE, Zaki SR, Shieh W, et al. Science 2000 288 1432 1435 10.1126/science.288.5470.1432 10827955 (Pubitemid 30366331)
8. Henipavirus vaccine development. Pallister J, Middleton D, Broder CC, Wang L-F, Journal of Bioterrorism and Biodefense 2011 S1 005
9. Hendra virus: an emerging paramyxovirus in Australia. Mahalingam S, Herrero LJ, Playford EG, Spann K, Herring B, Rolph MS, Middleton D, McCall B, Field H, Wang LF, Lancet Infect Dis 2012 12 799 807 10.1016/S1473-3099(12)70158- 5 22921953
10. Screening of bat carers for antibodies to equine morbillivirus. Selvey LA, Taylor R, Arklay A, Gerrard J, Communicable Disease Intelligence 1996 20 477 478
11. Transmission of human infection with Nipah virus. Luby SP, Gurley ES, Hossain MJ, Clin Infect Dis 2009 49 1743 1748 10.1086/647951 19886791
12. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Khetawat D, Broder CC, Virol J 2010 7 312 10.1186/1743-422X-7-312 21073718
13. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC, Proc Natl Acad Sci USA 2005 102 10652 10657 10.1073/pnas.0504887102 15998730 (Pubitemid 41061609)
14. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Muhlberger E, Su SV, Bertolotti-Ciarlet A, Flick R, Lee B, PLoS Pathog 2006 2 7 10.1371/journal.ppat.0020007 16477309
15. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage. Negrete OA, Chu D, Aguilar HC, Lee B, J Virol 2007 81 10804 10814 10.1128/JVI.00999-07 17652392 (Pubitemid 47463353)
16. Feline model of acute Nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, Russell G, Green D, McEachern J, Pritchard LI, Eaton BT, et al. J Virol 2006 80 12293 12302 10.1128/JVI.01619-06 17005664 (Pubitemid 44904379)
17. Immunization against viral diseases. Graham BS, Crowe JE, Fields Virology Philadelphia: Lippincott Williams & Wilkins, Knipe DM, Griffin DE, Lamb RA, Straus SE, Howley PM, Martin MA, Roizman B, 2007 487 538
18. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. Wolinsky JS, Waxham MN, Server AC, J Virol 1985 53 727 734 3973964 (Pubitemid 15128638)
19. Vaccination against the major infectious diseases. Plotkin SA, C R Acad Sci III 1999 322 943 951 10.1016/S0764-4469(00)87191-7 10646088
20. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, Middleton D, Feng YR, Broder CC, Wang LF, Bossart KN, Vaccine 2008 26 3842 3852 10.1016/j.vaccine.2008.05.016 18556094
21. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, Geisbert JB, Feng YR, Chan YP, Hickey AC, et al. Sci Transl Med 2012 4 146ra107 10.1126/scitranslmed.3004241 22875827
22. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR, et al. Vaccine 2011 29 5623 5630 10.1016/j.vaccine.2011.06.015 21689706
23. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute Nipah virus infection. Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, et al. PLoS Pathog 2009 5 1000642 10.1371/journal.ppat.1000642 19888339
24. A morbillivirus that caused fatal disease in horses and humans. Murray K, Selleck P, Hooper P, Hyatt A, Gould A, Gleeson L, Westbury H, Hiley L, Selvey L, Rodwell B, et al. Science 1995 268 94 97 10.1126/science.7701348 7701348
25. The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. Wang LF, Yu M, Hansson E, Pritchard LI, Shiell B, Michalski WP, Eaton BT, J Virol 2000 74 9972 9979 10.1128/JVI.74.21.9972-9979.2000 11024125
26. A summary of taxonomic changes recently approved by ICTV. Mayo MA, Arch Virol 2002 147 1655 1663 10.1007/s007050200039 12181683
27. Epidemiology of henipavirus disease in humans. Luby SP, Gurley ES, Curr Top Microbiol Immunol 2012 359 25 40 10.1007/82-2012-207 22752412
28. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge. Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, et al. Sci Transl Med 2011 3 105ra103 10.1126/scitranslmed.3002901 22013123
29. Fatal encephalitis due to novel paramyxovirus transmitted from horses. O'Sullivan JD, Allworth AM, Paterson DL, Snow TM, Boots R, Gleeson LJ, Gould AR, Hyatt AD, Bradfield J, Lancet 1997 349 93 95 10.1016/S0140-6736(96)06162-4 8996421 (Pubitemid 27023426)
30. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK, N Engl J Med 2000 342 1229 1235 10.1056/NEJM200004273421701 10781618 (Pubitemid 30235951)
31. Relapsed and late-onset Nipah encephalitis. Tan CT, Goh KJ, Wong KT, Sarji SA, Chua KB, Chew NK, Murugasu P, Loh YL, Chong HT, Tan KS, et al. Ann Neurol 2002 51 703 708 10.1002/ana.10212 12112075 (Pubitemid 34568848)
32. A new model for hendra virus encephalitis in the mouse. Dups J, Middleton D, Yamada M, Monaghan P, Long F, Robinson R, Marsh GA, Wang LF, PLoS One 2012 7 40308 10.1371/journal.pone.0040308 22808132
33. Invasion of the central nervous system in a porcine host by Nipah virus. Weingartl H, Czub S, Copps J, Berhane Y, Middleton D, Marszal P, Gren J, Smith G, Ganske S, Manning L, Czub M, J Virol 2005 79 7528 7534 10.1128/JVI.79.12. 7528-7534.2005 15919907 (Pubitemid 40756788)
34. Genetic characterization of Nipah virus, Bangladesh, 2004. Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ, et al. Emerg Infect Dis 2005 11 1594 1597 10.3201/eid1110.050513 16318702 (Pubitemid 41384348)
35. Nipah virus encephalitis outbreak over a wide area of western Bangladesh, 2004. ICDDRB, Health and Science Bulletin 2004 2 7 11
36. Experimental Nipah virus infection in pigs and cats. Middleton DJ, Westbury HA, Morrissy CJ, van der Heide BM, Russell GM, Braun MA, Hyatt AD, J Comp Pathol 2002 126 124 136 10.1053/jcpa.2001.0532 11945001